Cameron Hudson was an active boy who played basketball and excelled at karate. When he was eleven years old, he showed his parents a strange bump he found on his knee. After many doctors’ visits, he was diagnosed with a rare sarcoma – one of only 300 cases in the world.
During his treatment, Cameron found a very special source of comfort: Aries, a golden retriever therapy dog who showed up on the hardest days and somehow made them easier. Watching Aries trot through the halls, Cameron began dreaming of a dog of his own.
That dream arrived in the form of Lucky – a golden retriever gifted by generous friends who wanted to give Cameron something to love and plan for beyond the next round of chemo. From his hospital bed, Cameron threw himself into the role of dog owner the same way he approached everything: with focus, patience, and a motto he’d adopted as his own, “Slow and steady wins the race.” He watched puppy training videos for hours. He practiced commands. He was determined.
“That dog was so well-trained that she would sit in front of a bowl of food without moving until he told her it was okay,” recalled Cameron’s father, Michael. “Lucky gave him purpose.”
And then Cameron dreamed bigger. He wanted Lucky to one day have puppies that could go to help other children fighting cancer, just as Aries had helped him. It was the kind of idea only Cameron would have: in the middle of his own battle, thinking about how to make it easier for someone else.
Cameron passed away on June 28, 2023. But his parents, Katie and Michael, held onto his vision.
They found a wonderful golden retriever named Chester, and Lucky gave birth to ten healthy puppies in February. Each one found a home entirely by word of mouth, no advertising needed. Every dollar from the puppies’ sale is being donated to CURE, the organization that showed up for their family with meals, support, and community when they needed it most.
“I feel like Cameron handpicked the families,” Katie said. “And it is so special that he is still giving back. There were days in the hospital that I wouldn’t have eaten at all if it weren’t for CURE.”
One of the ten puppies is heading to a very special home. Chelsea Key from CURE’s Patient and Family Services team is adopting one of Lucky’s pups. She and her family hope to have her trained as a therapy dog when she gets a little older. The plan is for her to one day attend CURE events and visit patients, offering the same kind of comfort that Aries once gave Cameron.
Cameron never got to see it happen. But in a very real way, he made it happen. His spirit will carry on with each home that gets one of the puppies.
Lucky still lives with the Hudson family in Florida. And he reminds them of Cameron every single day.

If you spend a few minutes with Meme, you’ll learn she is a diva who loves the camera, dressing up, and the color pink. She’ll dance for you, or she’ll tell you she’s going to be a doctor, a police officer, or a teacher when she grows up. Chemo has made her more home-bound than before. But she’s filled the house with TikTok videos, joyful energy, and a spirit that makes everyone in her life cheer for her. She even worked hard to make the second-grade honor roll.


“As a young adult, you think you have your entire life ahead of you,” Lexi reflected. “But then you get served this stark reality that you might not be here tomorrow. What am I going to do with all of the other things I planned to do with my life?”


Webb was diagnosed before he could crawl, before he could sit up, and before he could speak. He has battled his whole life. What started as difficulty and eventual inability to eat led to difficulty gaining weight, and the inability to meet developmental milestones. Finally, at seven months old, Laura and Scott knew the reason why.

After two rounds of chemotherapy, Madeline regained her ability to walk. Surgeons managed to remove 85% of the tumor, though its connection to her spinal column prevented complete removal. Genetic testing through CURE’s Precision Medicine Program revealed a mutation associated with an aggressive form of neuroblastoma. But fortunately, the remnants of Madeline’s tumor have been stable. Knowing that Madeline has that particular genetic mutation will help doctors in the future should her tumor become active.
Genetic sequencing through CURE’s Precision Medicine Program revealed crucial information: her tumor carried a gene fusion called KIAA1549: BRAF. This discovery proved to be both a challenge and an opportunity. While traditional treatments would likely be less effective because of this mutation, the discovery opened the door to targeted therapies called MEK inhibitors that could block the activity of proteins that cause tumor growth.




One day, Chrisean called Machelle from school because his chest hurt badly. She took him to the children’s hospital, where the doctor pulled down his eyelid and noticed his skin was nearly white. When he ordered a blood test, the staff found a new problem – Chrisean was terrified of needles. He was so big that the nurses had to get two men and a security officer to hold him down to draw blood. The blood test revealed that Chrisean had acute lymphoblastic leukemia.

